Since research in this area is sparse, it is crucial for future studies to explore the role of neuroinflammation (especially biomarkers other than MCP-1) in animal models of HIV-associated depression and clarify whether blocking specific neuroinflammatory pathways may rescue HIV-related depressive-like behaviours. This evidence concerns the gene CCL2 and major depressive disorder.